分子检测技术员

Chinese research institute founded in January 2018 in Nanjing, Jiangsu, registered as a Jiangsu new-type research and development institution and a provincial postdoctoral innovation practice base, and part of the Chinese Academy of Sciences Qilin regional innovation ecosystem supporting the biomedical field. Works to the national strategy of serving people's life and health, pursuing breakthroughs in key theory and technology with translation of results as its goal and concentrating on novel vaccines, antibodies and molecular diagnostics. Runs three sub-platforms for common technology research and translation covering novel vaccines, antibodies and molecular and immunodiagnostics, aiming to build a national base for original innovation and commercialisation in life and health.